Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share (Details)

v3.22.2.2
Earnings (Loss) Per Share (Details) - $ / shares
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings Per Share [Abstract]          
Potentially dilutive shares from convertible securities outstanding   964,000 964,000 964,000 964,000
Outstanding unexercised warrants to purchase 8,900,000        
Common stock exercise price per share (in Dollars per share) $ 9.76        
Warrants expired Apr. 28, 2022